{"id":11416,"date":"2022-07-01T20:36:40","date_gmt":"2022-07-02T00:36:40","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/2019-frontiers-in-cancer-immunotherapy\/"},"modified":"2022-07-14T13:18:59","modified_gmt":"2022-07-14T17:18:59","slug":"frontiers-in-cancer-immunotherapy-2019","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/frontiers-in-cancer-immunotherapy-2019","title":{"rendered":"2019 Frontiers in Cancer Immunotherapy"},"content":{"rendered":"<p>Immuno-oncology promises a revolution in the way we treat cancer. Since the approval of the first checkpoint inhibitors in 2014, and the subsequent approval of the first cellular therapy in 2017, the field of cancer immunotherapy has exploded with numerous ongoing clinical trials. Despite great successes, emerging results suggest that monotherapies are not sufficient to treat many cancer types and it is increasingly clear that combinatorial approaches are needed to target heterogeneous tumors and improve variability in patient response.<\/p>\n<p>This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies. Particular emphasis will be given to the biological mechanisms underlying combination hypotheses, bispecific antibodies and other emerging modalities for delivery of combination therapies, as well as a discussion of the importance of biomarkers and effective clinical trial design.<\/p>\n<h3>Presented By<\/h3>\n<p>Cancer Discussion Group at&nbsp;The New York Academy of Sciences<\/p>\n<h3>Keynote Speaker<\/h3>\n<p>James P. Allison, PhD, MD Anderson Cancer Center&nbsp;<\/p>\n<h3>Call for Abstracts<\/h3>\n<p>Abstract submissions are invited for a poster session. The deadline for abstract submission is&nbsp;<strong>Friday, March 15, 2019.<\/strong><\/p>\n<p>The&nbsp;Cancer Research Institute is a promotional partner for this event.&nbsp;<\/p>\n<p>The event will take place at&nbsp;The New York Academy of Sciences,&nbsp;7 World Trade Center,&nbsp;<br \/>\n250 Greenwich St,&nbsp;Floor 40,&nbsp;New York, NY.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.<\/p>\n","protected":false},"featured_media":2351,"template":"","events_categories":[417],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11416","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-conferencias"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>2019 Frontiers in Cancer Immunotherapy<\/title>\n<meta name=\"description\" content=\"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"2019 Frontiers in Cancer Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-14T17:18:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1947b5e2-b123-49af-8a8e-07c82312f30f.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"2019 Frontiers in Cancer Immunotherapy\" \/>\n<meta name=\"twitter:description\" content=\"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1947b5e2-b123-49af-8a8e-07c82312f30f.png\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019\",\"name\":\"2019 Frontiers in Cancer Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/4525e8f4-2a79-4d39-b8e1-7e704210b0d6.png\",\"datePublished\":\"2022-07-02T00:36:40+00:00\",\"dateModified\":\"2022-07-14T17:18:59+00:00\",\"description\":\"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/4525e8f4-2a79-4d39-b8e1-7e704210b0d6.png\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/4525e8f4-2a79-4d39-b8e1-7e704210b0d6.png\",\"width\":1200,\"height\":630},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"2019 Frontiers in Cancer Immunotherapy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"2019 Frontiers in Cancer Immunotherapy","description":"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019","og_locale":"es_ES","og_type":"article","og_title":"2019 Frontiers in Cancer Immunotherapy","og_description":"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.","og_url":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019","og_site_name":"Cancer Research Institute","article_modified_time":"2022-07-14T17:18:59+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1947b5e2-b123-49af-8a8e-07c82312f30f.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"2019 Frontiers in Cancer Immunotherapy","twitter_description":"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/1947b5e2-b123-49af-8a8e-07c82312f30f.png","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019","url":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019","name":"2019 Frontiers in Cancer Immunotherapy","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/4525e8f4-2a79-4d39-b8e1-7e704210b0d6.png","datePublished":"2022-07-02T00:36:40+00:00","dateModified":"2022-07-14T17:18:59+00:00","description":"This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/4525e8f4-2a79-4d39-b8e1-7e704210b0d6.png","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/4525e8f4-2a79-4d39-b8e1-7e704210b0d6.png","width":1200,"height":630},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/frontiers-in-cancer-immunotherapy-2019#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"2019 Frontiers in Cancer Immunotherapy"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/2351"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11416"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11416"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11416"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11416"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11416"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11416"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}